Tobias Else
Associate Professor of Internal Medicine
Assistant Division Chief for Inpatient Endocrine Service
Section Head, Internal Medicine
Program Director of Fellowship, Endocrinology
Department of Internal Medicine, MEND
1150 W Med Ctr Dr
Ann Arbor, MI 48109
[email protected]

Available to mentor

Tobias Else
Associate Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
  • Qualifications
    • Metabolism, Endocrinology and Diabetes Fellowship
      University of Michigan, Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND), 2014
    • Internal Medicine Residency
      University of Michigan, Department of Internal Medicine, 2010
    • Adrenal development, tumorigenesis and telomere pathophysiology
      University of Michigan, MEND, 2008
    • MD
      University of Hamburg, Martinistrasse 52, 2000
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Belzutifan as the first-line treatment for a challenging von Hippel-Lindau-related retinal hemangioblastoma: successful treatment of a case and review of the literature.
      Aykut A, Else T, Demirci H. Can J Ophthalmol, 2024 Dec; 59 (6): e862 - e865. DOI:10.1016/j.jcjo.2024.05.025
      PMID: 39043253
    • Journal Article
      A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions.
      Shabet C, Kattapuram M, Burton A, Thoeny R, Nielsen H, Accardo ML, Smith EH, Koeppe E, Else T, Cha KB. Fam Cancer, 2024 Nov; 23 (4): 543 - 550. DOI:10.1007/s10689-024-00402-2
      PMID: 38822938
    • Journal Article
      Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.
      Wiley HE, Srinivasan R, Maranchie JK, Chhablani J, Iversen ABB, Kruse A, Jonasch E, Gombos DS, Else T, Demirci H, Maughan BL, Hartnett ME, Coleman HR, Fu W, Perini RF, Liu Y, Linehan WM, Chew EY, LITESPARK-004 Investigator Group - Ocular VHL . Ophthalmology, 2024 Nov; 131 (11): 1324 - 1332. DOI:10.1016/j.ophtha.2024.05.024
      PMID: 38849055
    • Journal Article
      A review of mitotane in the management of adrenocortical cancer.
      Del Rivero J, Else T, Hallanger-Johnson J, Kiseljak-Vassiliades K, Raj N, Reidy-Lagunes D, Srinivas S, Gilbert J, Vaidya A, Aboujaoude E, Bancos I, Tito Fojo A. Oncologist, 2024 Sep 6; 29 (9): 747 - 760. DOI:10.1093/oncolo/oyae084
      PMID: 39037424
    • Journal Article
      Incidental melanoma and thyroid cancer lead to diagnosis of Lynch syndrome and endometrial cancer: A case report.
      Kuo ME, Smith EH, Plotzke J, Chan M, Else T, Cha KB. JAAD Case Rep, 2024 Sep; 51: 66 - 68. DOI:10.1016/j.jdcr.2024.06.023
      PMID: 39188332
    • Journal Article
      European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency.
      Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, van Hulsteijn L, Husebye ES, Karavitaki N, Prete A, Vaidya A, Yedinak C, Dekkers OM. J Clin Endocrinol Metab, 2024 Jun 17; 109 (7): 1657 - 1683. DOI:10.1210/clinem/dgae250
      PMID: 38724043
    • Preprint
      Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.
      Flynn A, Pattison AD, Balachander S, Boehm E, Bowen B, Dwight T, Rosello F, Hofmann O, Martelotto L, Zethoven M, Kirschner LS, Else T, Fishbein L, Gill AJ, Tischler AS, Giordano T, Prodanov T, Noble JR, Reddel RR, Trainer AH, Ghayee HK, Bourdeau I, Elston M, Ishak D, Ngeow Yuen Yie J, Hicks RJ, Crona J, Åkerström T, Stålberg P, Dahia P, Grimmond S, Clifton-Bligh R, Pacak K, Tothill RW. 2024 Jun 25; DOI:10.21203/rs.3.rs-4410500/v1
      PMID: 38978571
    • Journal Article
      3-[18F]Fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) PET-A Novel Imaging Modality for Paraganglioma.
      Else T, Wong KK, Frey KA, Brooks AF, Viglianti BL, Raffel DM. J Endocr Soc, 2024 Apr 6; 8 (6): bvae049 DOI:10.1210/jendso/bvae049
      PMID: 38617812